# A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids

> **NCT00152256** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 239 (actual)

## Conditions studied

- Fibroid Uterus
- Leiomyoma
- Menorrhagia
- Metrorrhagia
- Uterine Fibroids

## Interventions

- **DRUG:** Asoprisnil
- **DRUG:** Asoprisnil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00152256
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2005-02
- **Final completion:** 2005-02
- **Target enrollment:** 239 (ACTUAL)
- **Last updated:** 2008-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152256, "A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00152256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*